Evidence map›Paper›PMID 37396761›Full record

ArticleFrontiers in neurology2023

Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease.

Gabriel Torrealba-Acosta, Eric Yu, Tanya Lobo-Prada, Javier Ruíz-Martínez, Ana Gorostidi-Pagola, Ziv Gan-Or, Kenneth Carazo-Céspedes, Jean-François Trempe, Ignacio F Mata, Jaime Fornaguera-Trías

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gabriel Torrealba-Acosta *Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
Eric Yu *Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Tanya Lobo-PradaNeurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica.
Javier Ruíz-MartínezGroup of Neurodegenerative Diseases, Biodonostia Health Research Institute, San Sebastian, Spain.
Ana Gorostidi-PagolaCIBERNED, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain.
Ziv Gan-OrMontreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Kenneth Carazo-CéspedesDepartment of Neurology, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, San José, Costa Rica.
Jean-François TrempeDepartment of Pharmacology and Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, QC, Canada.
Ignacio F MataCleveland Clinic Foundation, Genomic Medicine, Lerner Research Institute, Cleveland, OH, United States.
Jaime Fornaguera-TríasNeurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fneur.2021.656342.].

Indexed as

Costa RicagenotypeLatin AmericaParkinson's diseasephenotype

Identifiers

PMID37396761
PMCPMC10311411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.